The rise of new in vitro and in vivo model systems using human stem cell technologies and human tissues alongside with animal models have significantly increased the need for implementing electrophysiology as part of basic research methodologies. The application of electrophysiological methods possesses, however, challenges as those require deep methodological understanding, sophisticated instrumentation and dedicated laboratoty premises. The BF-Finnish Electrophysiology Platform, FinE, enables research groups and non-academic users even with no prior or low to high experience in electrophysiological recordings to utilize our centered services. FinE provides access to state-of-art (SoA) electrophysiological facilities and user training and expertise in planning and executing experiments. It brings multilevel expertise available for users and the ability to custom-design experiments regardless of model system (in vitro, ex vivo, in vivo). The SoA equipment and expertise include range of microelectrode array (MEA) technologies, patch clamp (PC), and fast fluorescence e.g., calcium (Ca) imaging. MEA’s are utilized in 2D with neuronal, cardiac and epithelial cells, and brain organoids and human/rodent tissue sections, in microfluidic chips with neuronal and cardiac cells, and in vivo with rodents. PC and Ca imaging are utilized mostly with 2D samples. Integration of MEA, PC, and Ca imaging for simultaneous recordings is also possible. High-resolution multi-site recordings of local field potentials (LFP), single neuron activity, electroencephalography (EEG), ECoG and fast scan cyclic voltammetry (FSCV) are utilized with in rodents in vivo. Optogenetics and behavioral testing is also possible.


The BF-Finnish Electrophysiology Platform services include:


  • Open access to all facilities (after user training)
  • Personal user support and general support activities: e.g., user training, consultation on experimental set up, sample preparation, choice of instruments, and data analysis
  • Full-service model including experimental design, conduction of the measurements and analyses, preparation of results to e.g., scientific articles.
  • Maintenance and development of equipment and methods
    Jointly develop algorithms and software for advanced data analysis
  • Teaching activities: lectures and practical courses for MSc & graduate students & postdoctoral fellows

Image

Image created with BioRender.com.

Nodes


Node/Host UniversityNode PI
FinE-TAU, Electrophysiological measurements
core facility, TAU
Susanna Narkilahti, susanna.narkilahti@tuni.fi
FinE-UEF, Core facility of in vitro and ex vivo
electrophysiology, UEF
Tarja Malm,
tarja.malm@uef.fi
FinE-UH, Helsinki Electrophysiology Platform, UH
Sari Lauri, sari.lauri@helsinki.fi

TAU: Tampere University; UEF: University of Eastern Finland; UH: University of Helsinki



Contact details


Platform Chair


Susanna Narkilahti
susanna.narkilahti@tuni.fi
Tampere University


Services


FinE-TAU, Electrophysiological measurements core facility
 
The core facility focuses on electrophysiological measurements of human stem cell and rodent derived cells e.g., neurons, cardiomyocytes and epithelial cells, and ex vivo tissues in conventional 2D settings and in microfluidics chips. Also, in-house built sensor and environmental control systems can be combined with measurements. The core instrumentation consists of three regular MEA systems, two fast fluorescence systems, two PC systems that can be used solely or in combination, and light stimulation option.

FinE-UEF, Core facility of in vitro and ex vivo electrophysiology

The core facility carries out electrophysiological measurements of human stem cell derived models and brain biopsies obtained from surgeries. The core is specialized on 3D samples and cellular models but has capacity to record from 2D cultures. The core instrumentation includes 2 PC systems, one regular MEA system and one high density MEA system, and one fast fluorescence system.

FinE-UH, Helsinki Electrophysiology Platform

The core facility provides facilities and services in various electrophysiological techniques, including PC, field potential and MEA recordings from acutely isolated and cultured neuronal preparations, as well as from rodent brain in vivo. The instrumentation includes visually guided PC setups, MEA systems for neuronal cultures and for head-fixed awake mice. Recordings can be combined with behavioral tasks, pharmacological and genetic manipulation as well as electrical and optogenetic stimulation.

Image
Image

Photographs by Jonne Renvall

Recent user publications


Kapucu FE, Tujula I, Kulta O, Sukki L, Ryynänen T, Gram H, Vuolanto V, Vinogradov A, Kreutzer J, Jensen PH, Kallio P, Narkilahti S. Human tripartite cortical network model for temporal assessment of alpha-synuclein aggregation and propagation in Parkinson's Disease. NPJ Parkinsons Dis. 2024 Jul 28;10(1):138. doi: 10.1038/s41531-024-00750-x

Scoyni F, Giudice L, Väänänen MA, Downes N, Korhonen P, Choo XY, Välimäki NN, Mäkinen P, Korvenlaita N, Rozemuller AJ, de Vries HE, Polo J, Turunen TA, Ylä-Herttuala S, Hansen TB, Grubman A, Kaikkonen MU, Malm T. Alzheimer's disease-induced phagocytic microglia express a specific profile of coding and non-coding RNAs. Alzheimer’s & Dementia 2023 Oct 12. doi: 10.1002/alz.13502


Ignatova, I.; Frolov, R.; Nymark, S. The Retinal Pigment Epithelium Displays Electrical Excitability and Lateral Signal Spreading. BMC Biology 2023, 21 (1), 84. https://doi.org/10.1186/s12915-023-01559-5.


Gazestani V, Kamath T, Nadaf NM, Dougalis A, Burris SJ, Rooney B, Junkkari A, Vanderburg C, Pelkonen A, Gomez-Budia M, Välimäki NN, Rauramaa T, Therrien M, Koivisto AM, Tegtmeyer M, Herukka SK, Abdulraouf A, Marsh SE, Hiltunen M, Nehme R, Malm T, Stevens B, Leinonen V, Macosko EZ. Early Alzheimer’s disease pathology in human cortex involves transient cell states. Cell. 2023 Sep 28;186(20)4438-4453. e23. doi: 10.1016/j.cell.2023.08.005.


Casarotto PC, Girych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, Biojone C, Cannarozzo C, Sahu MP, Kaurinkoski K, Brunello CA, Steinzeig A, Winkel F, Patil S, Vestring S, Serchov T, Diniz CRAF. Laukkanen L, Cardon I, Antila H, Rog T, Piepponen TP, Bramham CR, Normann C, Lauri SE, Saarma M, Vattulainen I, Castren E. (2021) Antidepressants act by directly binding to the TRKB neurotrophin receptors. Cell, 184(5):1299-1313.e19



Image
Image

Photographs by Jonne Renvall